Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.603
+0.015 (0.94%)
Jul 24, 2026, 5:29 PM CET
Oncopeptides AB Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Oncopeptides AB stock has a consensus rating of "Hold" and an average price target of kr 2.50. The average 1-year stock price forecast is 55.96% higher than the current stock price, while the lowest is kr 2.10 (+31.00%) and the highest is kr 3.10 (+93.39%).
Price Target: kr 2.50 (+55.96%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Oncopeptides AB stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 1 | 1 | 0 | 1 | 2 |
Financial Forecast
Revenue This Year
141.30M
from 71.12M
Increased by 98.68%
Revenue Next Year
239.43M
from 141.30M
Increased by 69.45%
EPS This Year
-0.47
from -1.10
EPS Next Year
-0.25
from -0.47
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.